Heterogeneity and treatment landscape of ovarian carcinoma

AC Veneziani, E Gonzalez-Ochoa, H Alqaisi… - Nature Reviews …, 2023 - nature.com
Ovarian carcinoma is characterized by heterogeneity at the molecular, cellular and
anatomical levels, both spatially and temporally. This heterogeneity affects response to …

[HTML][HTML] Molecular characteristics and clinical behaviour of epithelial ovarian cancers

RL Hollis - Cancer letters, 2023 - Elsevier
Ovarian carcinoma (OC) is an umbrella term for multiple distinct diseases (histotypes), each
with their own developmental origins, clinical behaviour and molecular profile. Accordingly …

[HTML][HTML] Low-grade serous ovarian cancer: expert consensus report on the state of the science

RN Grisham, BM Slomovitz, N Andrews… - International Journal of …, 2023 - Elsevier
Compared with high-grade serous carcinoma, low-grade serous carcinoma of the ovary or
peritoneum is a less frequent epithelial ovarian cancer type that is poorly sensitive to …

[HTML][HTML] The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis

CSE Hendrikse, PMM Theelen, P Van Der Ploeg… - Gynecologic …, 2023 - Elsevier
Abstract Background The RAS/RAF/MEK/ERK (MAPK) pathway plays a role in ovarian
carcinogenesis. Low-grade serous ovarian carcinoma (LGSOC) frequently harbors …

Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma

RL Hollis, JP Thomson, J van Baal, N Ilenkovan… - Scientific reports, 2023 - nature.com
Low grade serous ovarian carcinoma (LGSOC) demonstrates unique clinical and molecular
features compared to other ovarian cancer types. The relationship between common …

Somatic genomic and transcriptomic characterization of primary ovarian serous borderline tumors and low-grade serous carcinomas

I Stružinská, N Hájková, J Hojný, E Krkavcová… - The Journal of Molecular …, 2024 - Elsevier
Low-grade serous carcinoma (LGSC) may develop from serous borderline tumor (SBT)
tissue, where the micropapillary type (mSBT) presents the highest risk for progression. The …

Early genetic divergence of high-grade carcinomas originating from low-grade serous ovarian neoplasms

MH Chui, Q Song, J Zhu, Y Jiao, B Wang, Y Wang… - Modern Pathology, 2025 - Elsevier
The current paradigm implicates a fallopian tube precursor as the origin of most ovarian high-
grade serous carcinomas (HGSCs). However, a rare subset of HGSCs develop via a distinct …

Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: readdressing the roles of platinum and cytotoxic therapies

BL Manning‐Geist, RM Kahn, D Nemirovsky… - Cancer, 2023 - Wiley Online Library
Background Data on platinum sensitivity of low‐grade serous ovarian carcinoma (LGSOC)
in the upfront setting is lacking, and there is limited and contradictory information on …

Molecular results and potential biomarkers identified from the phase 3 MILO/ENGOT-ov11 study of binimetinib versus physician choice of chemotherapy in recurrent …

RN Grisham, I Vergote, S Banerjee, E Drill… - Clinical cancer …, 2023 - aacrjournals.org
Purpose: We present the results of a post hoc tumor tissue analysis from the phase 3
MILO/ENGOT-ov11 study (NCT01849874). Patients and Methods: Mutation/copy-number …

[HTML][HTML] Novel Targeted Agents in Advanced and Recurrent Low-Grade Serous Ovarian Cancer: A Silver Lining in the Therapy of a Chemoresistant Disease?

A Onoprienko, T Bartl, C Grimm, N Concin… - Cancers, 2024 - mdpi.com
Simple Summary Low-grade serous ovarian cancer is a rare and complex subtype that
usually develops slowly and predominantly affects younger women. Conventional treatment …